Ikarian Capital, LLC

In its 13F for Q1 2026 (holdings as of March 31, 2026, filed May 15, 2026), Ikarian Capital, LLC reported 127 stock positions worth $699.0 million. Its top holding was Terns Pharmaceuticals (TERN) at 11.0% of the portfolio, followed by Kodiak Sciences (KOD, 6.9%) and Alumis (ALMS, 3.8%). Compared with Q4 2025, it opened 16 new positions, sold out of 24, added to 28 and reduced 18. The biggest buy was Kodiak Sciences (KOD, shares +76%) and the biggest sale an exit from Cidara Therapeutics (CDTX).

Most Recent 13F
Q2 2026
Location
DALLAS, TX
CIK
0001778253
Portfolio Value
$699.0M (Q1 2026)
SEC Filing
0001420506-26-001165 ↗ filed May 15, 2026

Holdings Value

0$200.0M$400.0M$600.0M$800.0M Q1 2024: $367.7M Q1 2024 Q2 2024: $320.5M Q2 2024 Q3 2024: $322.0M Q3 2024 Q4 2024: $350.2M Q4 2024 Q1 2025: $306.9M Q1 2025 Q2 2025: $302.2M Q2 2025 Q3 2025: $494.3M Q3 2025 Q4 2025: $772.6M Q4 2025 Q1 2026: $699.0M $699.0M Q1 2026 Q2 2026: $610.9M Q2 2026

Holdings 127 stocks · $699.0M
TERN Terns Pharmaceuticals Inc. 10.98% 1,456,378 $76.8M Reduce -8.8%
KOD Kodiak Sciences Inc. 6.90% 1,265,795 $48.3M Add +75.9%
ALMS Alumis Inc. 3.82% 1,213,548 $26.7M New
PCVX Vaxcyte Inc. 3.56% 428,682 $24.9M Add +13.2%
PRAX Praxis Precision Medicines I 3.30% 71,581 $23.1M Reduce -17.3%
HROW Harrow Inc. 2.74% 543,047 $19.1M Add +196.2%
RLMD Relmada Therapeutics Inc. 2.68% 2,688,359 $18.7M Reduce -12.4%
CYTK Cytokinetics Inc. 2.67% 283,572 $18.7M Add +64.2%
TENX Tenax Therapeutics Inc. 2.33% 1,017,600 $16.3M Add +5.2%
CAPR Capricor Therapeutics Inc. 2.30% 528,015 $16.1M Reduce -8.7%
RVMD Revolution Medicines Inc. 2.27% 163,142 $15.9M Add +18.1%
CLDX Celldex Therapeutics Inc. 2.09% 461,247 $14.6M New
PHVS Pharvaris NV 1.97% 486,856 $13.8M No change
CNTB Connect Biopharma Holdings L 1.88% 5,388,486 $13.1M Add +12.5%
DRUG Bright Minds Biosciences Inc. 1.74% 166,647 $12.2M Add +4.5%
BBIO Bridgebio Pharma Inc. 1.70% 160,120 $11.9M New
ORKA Oruka Therapeutics Inc. 1.70% 242,021 $11.9M New
ANRO Alto Neuroscience Inc. 1.66% 515,000 $11.6M No change
SLNO Soleno Therapeutics Inc. 1.65% 344,123 $11.5M Add +400.0%
MAZE Maze Therapeutics Inc. 1.62% 378,999 $11.3M Reduce -41.2%
ANIP Ani Pharmaceuticals Inc. 1.62% 147,085 $11.3M New
CTNM Contineum Therapeutics Inc. Class A 1.51% 807,874 $10.6M Add +185.6%
RARE Ultragenyx Pharmaceutical Inc. 1.45% 482,571 $10.1M Add +3708.5%
IONS Ionis Pharmaceuticals Inc. 1.36% 127,038 $9.5M Reduce -37.1%
OLMA Olema Pharmaceuticals Inc. 1.28% 598,281 $8.9M Reduce -21.1%
EPRX Eupraxia Pharmaceuticals Inc. 1.26% 1,214,741 $8.8M Add +99.1%
DMRA Damora Therapeutics Inc. 1.24% 335,710 $8.7M Add +17.5%
PVLA Palvella Therapeutics Inc. 1.15% 64,626 $8.1M New
FULC Fulcrum Therapeutics Inc. 1.15% 1,049,161 $8.0M Reduce -23.7%
VERA Vera Therapeutics Inc. 1.15% 200,000 $8.0M New
SPRB Spruce Biosciences Inc. 1.13% 121,356 $7.9M No change
IVA Inventiva SA - ADR 1.12% 1,429,101 $7.8M Add +184.3%
JBIO Jade Biosciences Inc. 1.03% 512,349 $7.2M Add +70.8%
OCGN Ocugen Inc. 1.03% 3,962,972 $7.2M New
ZURA Zura Bio Ltd. 1.02% 1,193,492 $7.1M Add +48.8%
OVID Ovid Therapeutics Inc. 0.92% 2,894,704 $6.4M Add +1069.3%
ABVX Abivax SA-ADR 0.89% 57,635 $6.2M Reduce -72.0%
LLY Eli Lilly & Co. 0.86% 6,547 $6.0M Reduce -52.6%
ACOG Alpha Cognition Inc. 0.83% 1,056,259 $5.8M No change
PTHS Pelthos Therapeutics Inc. 0.77% 256,598 $5.4M Add +0.3%
SRZN Surrozen Inc. 0.72% 173,107 $5.0M Add +163.1%
TECX Tectonic Therapeutic Inc. 0.70% 157,537 $4.9M New
ALEC Alector Inc. 0.64% 2,082,606 $4.5M No change
LEGN Legend Biotech Corp.-ADR 0.59% 226,888 $4.1M No change
KPTI Karyopharm Therapeutics Inc. 0.58% 733,435 $4.1M Add +34.7%
LPCN Lipocine Inc. 0.58% 508,556 $4.1M Add +154.9%
DCTH Delcath Systems Inc. 0.57% 431,251 $4.0M No change
ARVN Arvinas Inc. 0.54% 358,257 $3.8M No change
CMPS Compass Pathways PLC 0.53% 675,000 $3.7M Add +68.8%
CRDL Cardiol Therapeutics Inc. Class A 0.53% 2,725,000 $3.7M New
BHVN Biohaven Ltd. 0.50% 412,481 $3.5M Add +94.1%
IVVD Invivyd Inc. 0.49% 2,656,570 $3.5M No change
ANNX Annexon Inc. 0.46% 580,244 $3.2M Add +152.0%
FBRX Forte Biosciences Inc. 0.44% 118,972 $3.1M Reduce -60.3%
LXEO Lexeo Therapeutics Inc. 0.42% 513,011 $2.9M No change
FRNM Freenome Inc. filed as PERCEPTIVE CAP SOLUTIONS COR 0.38% 240,951 $2.6M No change
VIR Vir Biotechnology Inc. 0.38% 293,258 $2.6M Reduce -49.1%
NXTC Nextcure Inc. 0.36% 238,303 $2.5M No change
NMRA Neumora Therapeutics Inc. 0.36% 1,278,408 $2.5M No change
ABOS Acumen Pharmaceuticals Inc. 0.36% 1,053,797 $2.5M Add +314.4%
CABA Cabaletta Bio Inc. 0.35% 900,000 $2.4M No change
BBOT Bridgebio Oncology Therapeut 0.35% 270,231 $2.4M Add +22.7%
PRQR Proqr Therapeutics NV 0.35% 1,492,229 $2.4M No change
NUVL Nuvalent Inc. Class A 0.35% 23,594 $2.4M Reduce -60.4%
JAZZ Jazz Pharmaceuticals PLC 0.34% 12,460 $2.4M Reduce -92.2%
DBVT DBV Technologies SA-Spon ADR 0.31% 525,000 $2.2M No change
TARS Tarsus Pharmaceuticals Inc. 0.31% 31,166 $2.2M No change
KLRS Kalaris Therapeutics Inc. 0.30% 360,000 $2.1M No change
AVR Anteris Technologies Global 0.29% 366,571 $2.0M New
SLDB Solid Biosciences Inc. 0.27% 264,409 $1.9M Add +64.8%
IBIO Ibio Inc. 0.26% 957,062 $1.8M No change
CPIX Cumberland Pharmaceuticals 0.26% 553,153 $1.8M Reduce -0.5%
SLN Silence Therapeutics PLC-ADR 0.25% 865,784 $1.7M No change
LABD Dire DLY SP BT Be 3X ETF-Usd 0.25% 105,822 $1.7M Add +159.2%
QURE Uniqure NV 0.21% 91,060 $1.5M No change
QNRX Quoin Pharmaceuticals LT-ADR 0.20% 211,538 $1.4M No change
TRAW Traws Pharma Inc. 0.18% 678,142 $1.2M No change
DERM Journey Medical Corp. 0.17% 251,436 $1.2M No change
VSTM Verastem Inc. 0.16% 213,865 $1.1M No change
DFTX Definium Therapeutics Inc. 0.16% 58,803 $1.1M No change
STIM Neuronetics Inc. 0.15% 701,182 $1.0M No change
LYEL Lyell Immunopharma Inc. 0.12% 41,081 $824K No change
PEPG Pepgen Inc. 0.11% 447,165 $791K No change
KZR Kezar Life Sciences Inc. 0.11% 102,211 $758K No change
IMUX Immunic Inc. 0.11% 674,662 $749K No change
CNTA Centessa Pharmaceuticals Ltd. 0.10% 18,113 $719K New
KALV Kalvista Pharmaceuticals Inc. 0.10% 35,119 $707K No change
PMN Promis Neurosciences Inc. 0.10% 55,000 $699K New
INSM Insmed Inc. 0.10% 4,214 $689K Reduce -54.9%
HELP Cybin Inc. 0.09% 132,153 $634K No change
ACAD Acadia Pharmaceuticals Inc. 0.09% 28,099 $625K New
WVE Wave Life Sciences Ltd. 0.09% 85,285 $618K No change
EQ Equillium Inc. 0.09% 303,555 $607K No change
PASG Passage Bio Inc. 0.08% 68,124 $535K New
GUTS Fractyl Health Inc. 0.07% 1,100,000 $504K No change
PALI Palisade Bio Inc. 0.07% 274,978 $481K No change
IMTX Immatics NV 0.07% 48,569 $478K No change
VKTX Viking Therapeutics Inc. 0.05% 9,717 $316K No change
SGMOQ Sangamo Therapeutics Inc. 0.04% 1,218,671 $301K No change
VTGN Vistagen Therapeutics Inc. 0.04% 519,077 $297K No change
VERU Veru Inc. 0.04% 133,517 $295K No change
EVAX Evaxion A/S 0.04% 74,698 $278K No change
LXRX Lexicon Pharmaceuticals Inc. 0.04% 164,674 $257K No change
ANL Adlai Nortye Group Ltd. 0.03% 33,899 $235K New
MGNX Macrogenics Inc. 0.03% 74,893 $216K No change
VYGR Voyager Therapeutics Inc. 0.03% 53,063 $205K No change
FTH Faeth Therapeutics Inc. filed as SENSEI BIOTHERAPEUTICS INC 0.03% 6,351 $200K Reduce -70.3%
NEUP Neuphoria Therapeutics Inc. 0.03% 47,443 $193K No change
VYNE THERAPEUTICS INC 0.02% 264,912 $158K No change
PURR Hyperliquid Strategies 0.02% 30,001 $153K No change
NYXH Nyxoah SA 0.02% 47,358 $138K No change
RNAC Cartesian Therapeutics Inc. 0.02% 20,807 $128K No change
PMVP PMV Pharmaceuticals Inc. 0.02% 89,136 $111K No change
CNSP CNS Pharmaceuticals Inc. 0.02% 45,830 $110K No change
CMPX Compass Therapeutics Inc. 0.01% 18,000 $95K Reduce -97.8%
IOBTQ Io Biotech Inc. 0.01% 1,386,565 $81K No change
CMMB Chemomab Therapeutics Ltd. 0.01% 51,793 $81K No change
BIOMX INC 0.01% 19,473 $73K No change
RZLT Rezolute Inc. 0.01% 16,479 $50K No change
MGRX Mangoceuticals Inc. 0.01% 138,146 $50K No change
SHUTTLE PHARMACTCLS HLDGS IN 0.01% 68,993 $47K No change
AIRS Airsculpt Technologies Inc. 0.01% 16,398 $46K No change
AETHLON MED INC 0.00% 14,364 $31K No change
GCTK Glucotrack Inc. 0.00% 45,830 $30K No change
TOVX Theriva Biologics Inc. 0.00% 112,076 $22K No change
JSPR Jasper Therapeutics Inc. 0.00% 24,093 $21K No change
AUTONOMIX MED INC 0.00% 18,688 $7K No change

Options reported separately and not counted above: XBI puts ($102.2M), TERN puts ($63.3M), QQQ puts ($57.7M), IWM puts ($49.6M), CYTK puts ($36.3M), ABVX calls ($32.7M), BMY puts ($30.3M), CYTK calls ($26.9M), NVO calls ($14.7M), ANIP calls ($11.5M), CAPR calls ($10.6M), RVMD puts ($9.2M), and 22 more.

Portfolio Sells Q4 2025 → Q1 2026
CDTX Cidara Therapeutics Inc. Sold out 0.00% −7.81
JAZZ Jazz Pharmaceuticals PLC Reduce -92.2% 0.34% −3.19
RAPT Rapt Therapeutics Inc. Sold out 0.00% −2.92
ABVX Abivax SA-ADR Reduce -72.0% 0.89% −2.88
AMGN Amgen Inc. Sold out 0.00% −1.91
MAZE Maze Therapeutics Inc. Reduce -41.2% 1.62% −1.84
CTMX Cytomx Therapeutics Inc. Sold out 0.00% −1.75
CELC Celcuity Inc. Sold out 0.00% −1.36
OLMA Olema Pharmaceuticals Inc. Reduce -21.1% 1.28% −1.18
PTCT PTC Therapeutics Inc. Sold out 0.00% −1.17
VTYX Ventyx Biosciences Inc. Sold out 0.00% −1.12
CGON CG Oncology Inc. Sold out 0.00% −1.07
LLY Eli Lilly & Co. Reduce -52.6% 0.86% −1.06
NBIX Neurocrine Biosciences Inc. Sold out 0.00% −0.99
MLYS Mineralys Therapeutics Inc. Sold out 0.00% −0.94
FULC Fulcrum Therapeutics Inc. Reduce -23.7% 1.15% −0.86
CORT Corcept Therapeutics Inc. Sold out 0.00% −0.84
IONS Ionis Pharmaceuticals Inc. Reduce -37.1% 1.36% −0.70
FBRX Forte Biosciences Inc. Reduce -60.3% 0.44% −0.62
ADMA Adma Biologics Inc. Sold out 0.00% −0.55
CMPX Compass Therapeutics Inc. Reduce -97.8% 0.01% −0.54
KRYS Krystal Biotech Inc. Sold out 0.00% −0.47
TGTX TG Therapeutics Inc. Sold out 0.00% −0.45
NUVL Nuvalent Inc. Class A Reduce -60.4% 0.35% −0.43
AGIO Agios Pharmaceuticals Inc. Sold out 0.00% −0.41
ERAS Erasca Inc. Sold out 0.00% −0.35
APLS Apellis Pharmaceuticals Inc. Sold out 0.00% −0.23
NAMS Newamsterdam Pharma Co. NV Sold out 0.00% −0.21
CPRX Catalyst Pharmaceuticals Inc. Sold out 0.00% −0.17
INSM Insmed Inc. Reduce -54.9% 0.10% −0.11
VIR Vir Biotechnology Inc. Reduce -49.1% 0.38% −0.07
AVTX Avalo Therapeutics Inc. Sold out 0.00% −0.07
GPCR Structure Therapeutics Inc. Sold out 0.00% −0.04
CPIX Cumberland Pharmaceuticals Reduce -0.5% 0.26% −0.03
LYRA Lyra Therapeutics Inc. Sold out 0.00% −0.01
PRAX Praxis Precision Medicines I Reduce -17.3% 3.30% −0.00
SYBX Synlogic Inc. Sold out 0.00% −0.00
ANEB Anebulo Pharmaceuticals Inc. Sold out 0.00% −0.00
FTH Faeth Therapeutics Inc. Reduce -70.3% 0.03% −0.00
CAPR Capricor Therapeutics Inc. Reduce -8.7% 2.30% +0.14
RLMD Relmada Therapeutics Inc. Reduce -12.4% 2.68% +0.76
TERN Terns Pharmaceuticals Inc. Reduce -8.8% 10.98% +2.64

Portfolio Buys Q4 2025 → Q1 2026
KOD Kodiak Sciences Inc. Add +75.9% 6.90% +4.30
ALMS Alumis Inc. New 3.82% +3.82
CLDX Celldex Therapeutics Inc. New 2.09% +2.09
BBIO Bridgebio Pharma Inc. New 1.70% +1.70
ORKA Oruka Therapeutics Inc. New 1.70% +1.70
ANIP Ani Pharmaceuticals Inc. New 1.62% +1.62
HROW Harrow Inc. Add +196.2% 2.74% +1.58
RARE Ultragenyx Pharmaceutical Inc. Add +3708.5% 1.45% +1.41
PCVX Vaxcyte Inc. Add +13.2% 3.56% +1.30
CYTK Cytokinetics Inc. Add +64.2% 2.67% +1.25
SLNO Soleno Therapeutics Inc. Add +400.0% 1.65% +1.24
PVLA Palvella Therapeutics Inc. New 1.15% +1.15
VERA Vera Therapeutics Inc. New 1.15% +1.15
CTNM Contineum Therapeutics Inc. Class A Add +185.6% 1.51% +1.09
OCGN Ocugen Inc. New 1.03% +1.03
OVID Ovid Therapeutics Inc. Add +1069.3% 0.92% +0.87
RVMD Revolution Medicines Inc. Add +18.1% 2.27% +0.85
IVA Inventiva SA - ADR Add +184.3% 1.12% +0.82
TENX Tenax Therapeutics Inc. Add +5.2% 2.33% +0.80
TECX Tectonic Therapeutic Inc. New 0.70% +0.70
EPRX Eupraxia Pharmaceuticals Inc. Add +99.1% 1.26% +0.66
SRZN Surrozen Inc. Add +163.1% 0.72% +0.53
CRDL Cardiol Therapeutics Inc. Class A New 0.53% +0.53
ZURA Zura Bio Ltd. Add +48.8% 1.02% +0.47
JBIO Jade Biosciences Inc. Add +70.8% 1.03% +0.43
DMRA Damora Therapeutics Inc. Add +17.5% 1.24% +0.39
LPCN Lipocine Inc. Add +154.9% 0.58% +0.37
ANNX Annexon Inc. Add +152.0% 0.46% +0.31
AVR Anteris Technologies Global New 0.29% +0.29
ABOS Acumen Pharmaceuticals Inc. Add +314.4% 0.36% +0.29
BHVN Biohaven Ltd. Add +94.1% 0.50% +0.19
CMPS Compass Pathways PLC Add +68.8% 0.53% +0.18
SLDB Solid Biosciences Inc. Add +64.8% 0.27% +0.16
LABD Dire DLY SP BT Be 3X ETF-Usd Add +159.2% 0.25% +0.14
DRUG Bright Minds Biosciences Inc. Add +4.5% 1.74% +0.13
CNTB Connect Biopharma Holdings L Add +12.5% 1.88% +0.13
CNTA Centessa Pharmaceuticals Ltd. New 0.10% +0.10
PMN Promis Neurosciences Inc. New 0.10% +0.10
ACAD Acadia Pharmaceuticals Inc. New 0.09% +0.09
PASG Passage Bio Inc. New 0.08% +0.08
KPTI Karyopharm Therapeutics Inc. Add +34.7% 0.58% +0.07
ANL Adlai Nortye Group Ltd. New 0.03% +0.03
BBOT Bridgebio Oncology Therapeut Add +22.7% 0.35% −0.01
PTHS Pelthos Therapeutics Inc. Add +0.3% 0.77% −0.26

Options Activity Q4 2025 → Q1 2026
XBI SS SPDR S&P Biotech ETF put Reduce -5.9% 800,000 $102.2M
CDTX Cidara Therapeutics Inc. put Sold out 300,000 $66.3Mbefore exit
AMGN Amgen Inc. put Sold out 200,000 $65.5Mbefore exit
TERN Terns Pharmaceuticals Inc. put New 1,200,000 $63.3M
QQQ Invesco QQQ Trust Series 1 put New 100,000 $57.7M
IWM iShares Russell 2000 ETF put New 200,000 $49.6M
CYTK Cytokinetics Inc. put New 550,500 $36.3M
ABVX Abivax SA-ADR call Add +134.4% 293,300 $32.7M
BMY Bristol-Myers Squibb Co. put New 500,000 $30.3M
JAZZ PHARMACEUTICALS PLC call Sold out 170,000 $28.9Mbefore exit
CYTK Cytokinetics Inc. call Add +40.4% 408,400 $26.9M
HROW Harrow Inc. call Sold out 509,700 $25.0Mbefore exit
SLNO Soleno Therapeutics Inc. call Sold out 528,900 $24.5Mbefore exit
CRNX Crinetics Pharmaceuticals Inc. put Sold out 368,500 $17.2Mbefore exit
OMER Omeros Corp. put Sold out 950,000 $16.3Mbefore exit
NVO Novo-Nordisk A/S-Spons ADR call New 400,000 $14.7M
ANIP Ani Pharmaceuticals Inc. call Add +81.2% 150,000 $11.5M
CAPR Capricor Therapeutics Inc. call New 350,000 $10.6M
RAPT Rapt Therapeutics Inc. call Sold out 290,000 $9.8Mbefore exit
OMER Omeros Corp. call Sold out 550,000 $9.4Mbefore exit
RVMD Revolution Medicines Inc. put New 95,000 $9.2M
DXCM Dexcom Inc. call Sold out 137,500 $9.1Mbefore exit
IONS Ionis Pharmaceuticals Inc. call Add +18.5% 112,100 $8.4M
CORT Corcept Therapeutics Inc. put Sold out 236,700 $8.2Mbefore exit
OLMA Olema Pharmaceuticals Inc. call Add +174.9% 549,800 $8.2M
APLS Apellis Pharmaceuticals Inc. call Sold out 325,600 $8.2Mbefore exit
RVMD Revolution Medicines Inc. call Sold out 95,000 $7.6Mbefore exit
NBIX Neurocrine Biosciences Inc. call Sold out 51,000 $7.2Mbefore exit
AVTX Avalo Therapeutics Inc. call Add +591.0% 401,500 $6.0M
RARE Ultragenyx Pharmaceutical Inc. put Sold out 255,100 $5.9Mbefore exit
ALMS Alumis Inc. call New 264,600 $5.8M
UNIQURE NV call Add +236.8% 355,000 $5.8M
RARE Ultragenyx Pharmaceutical Inc. call Sold out 250,000 $5.8Mbefore exit
CORT Corcept Therapeutics Inc. call Sold out 163,800 $5.7Mbefore exit
KPTI Karyopharm Therapeutics Inc. put New 920,000 $5.1M
KPTI Karyopharm Therapeutics Inc. call New 920,000 $5.1M
EYPT Eyepoint Inc. call New 370,400 $4.8M
EYPT Eyepoint Inc. put New 370,400 $4.8M
BBIO Bridgebio Pharma Inc. call New 58,500 $4.3M
KYMR Kymera Therapeutics Inc. put New 50,400 $4.2M
KOD Kodiak Sciences Inc. call New 100,000 $3.8M
AGIO Agios Pharmaceuticals Inc. call Sold out 137,200 $3.7Mbefore exit
CLDX Celldex Therapeutics Inc. put New 114,000 $3.6M
ARWR Arrowhead Pharmaceuticals Inc. put New 57,500 $3.6M
ELVN Enliven Therapeutics Inc. put New 83,700 $3.3M
AQST Aquestive Therapeutics Inc. put Sold out 500,000 $3.2Mbefore exit
VERA Vera Therapeutics Inc. call New 71,700 $2.9M
SLDB Solid Biosciences Inc. call Sold out 424,000 $2.4Mbefore exit
AVTX Avalo Therapeutics Inc. put New 158,500 $2.4M
REPL Replimune Group Inc. put New 300,000 $2.3M

Showing the first 50 of 61.

Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 126$610.9MABVX, KOD, ALMS, PRAX, PCVX
Q1 2026 127$699.0MTERN, KOD, ALMS, PCVX, PRAX
Q4 2025 135$772.6MTERN, CDTX, ABVX, JAZZ, MAZE
Q3 2025 116$494.3MGMAB, ABVX, IONS, CDTX, MAZE
Q2 2025 103$302.2MCDTX, ALNY, INSM, VRNA, CRNX
Q1 2025 116$306.9MTARS, CRNX, SPY, SRPT, BPMC
Q4 2024 122$350.2MTARS, CRNX, SRRK, BPMC, FBRX
Q3 2024 96$322.0MTARS, CRNX, ELVN, RCUS, VRDN
Q2 2024 85$320.5MSRPT, CRNX, TARS, SLNO, CRBP
Q1 2024Amended 82$367.7MCRNX, TARS, SLNO, CRBP, SRPT